Research programme: S-lansoprazole - SepracorAlternative Names: (S)-lansoprazole
Latest Information Update: 25 Mar 2017
At a glance
- Originator Sepracor
- Mechanism of Action Proton pump inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Gastro-oesophageal reflux
Most Recent Events
- 31 Aug 2006 Discontinued - Preclinical for Gastro-oesophageal reflux in USA (PO)
- 18 Apr 2001 New profile
- 18 Apr 2001 Preclinical development for Gastro-oesophageal reflux in USA (PO)